Massachusetts General Hospital

March 29, 2019March 29, 2019

MTPA, Massachusetts General Launching Study on Biomarkers of Radicava Response

News

Mitsubishi Tanabe Pharma America (MTPA), in collaboration with the Massachusetts General Hospital (MGH), is conducting a study to identify biomarkers related to amyotrophic lateral sclerosis (ALS), which may be helpful to ... Read more

March 21, 2019March 21, 2019

Amylyx Completes Patient Recruitment for Phase 2 Study Testing AMX0035 for ALS

News

Amylyx has completed patient recruitment for the Phase 2 clinical trial CENTAUR, which addresses the safety and effectiveness of AMX0035 as an oral treatment for amyotrophic lateral sclerosis (ALS). In 2017, Amylyx ... Read more

January 7, 2019January 7, 2019

FDA Awards Fast Track Status to Revalesio’s RNS60 for ALS; Phase 2 Trial Recruiting

News

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Revalesio’s experimental therapy RNS60 for people diagnosed with amyotrophic lateral sclerosis (ALS). A phase 2 trial ... Read more

December 6, 2018December 6, 2018

Affiliated Managers Group Gives $20M to Help Establish ALS Research Center

News

Global asset management company Affiliated Managers Group (AMG) has announced a $20 million matching gift to establish the Healey Center at Massachusetts General Hospital, the goal of which is to ... Read more

May 7, 2018May 7, 2018

Muscular Dystrophy Association, ALS ONE Form Partnership to Find New ALS Biomarkers

News

The Muscular Dystrophy Association (MDA) recently awarded the Massachusetts General Hospital (MGH) a $750,000 human clinical trial grant to study positron emission tomography (PET) imaging to measure inflammation in ... Read more

July 19, 2017

Boston and San Francisco Hospitals Will Take Part in Phase 3 Trial of NurOwn for ALS

News

Massachusetts General Hospital in Boston and California Pacific Medical Center in San Francisco will be among the sites where ALS patients will take in a Phase 3 clinical trial of BrainStorm Cell ... Read more

January 26, 2016January 26, 2016

New ALS Group’s Goal: Finding a New Treatment by 2020

News

Entrepreneur Kevin Gosnell announced the launch of ALS ONE – a partner organization of the ALS Association and ALS Finding a Cure that aims to bring world-leading experts in neurology ... Read more

September 16, 2015September 16, 2015

Johns Hopkins, Cedars-Sinai, and Massachusetts General Partner in Largest Project for Answer ALS

News

Three prominent health institutions have recently come together to form the country’s largest coordinated and comprehensive initiative against amyotrophic lateral sclerosis (ALS). Last week, Johns Hopkins University’s Robert Packard Center for ... Read more

Pin It on Pinterest